AXL TARGETING WITH BEMCENTINB RESTORES PD-1 BLOCKADE SENSITIVITY OF STK11/LKB1 MUTANT NSCLC THROUGH INNATE IMMUNE CELL MEDIATED EXPANSION OF TCF1+CD8 T CELLSJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62021-11-101OA
DUAL TARGETING OF CTLA-4 AND CD47 ON TREG CELLS REJUVENATES IMMUNITY AGAINST SOLID TUMORSJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62021-11-100OA